Luis Blanco, co-founder and science advisor at SYGNIS, receives Carmen y Severo Ochoa Molecular Biology Research Award
- Luis Blanco, PhD in Biology, is co-founder of X-Pol (currently SYGNIS Biotech), where he is a science advisor.
Madrid, 17 November 2014. – Professor and researcher Dr Luis Blanco has been granted the prestigious Carmen y Severo Ochoa Molecular Biology Research Award 2014. The prize, awarded by the Carmen y Severo Ochoa Foundation, is a recognition of Dr Blanco’s research in the field of molecular biology. The award gala took place on 12 November at the Madrid Student Residence.
Dr Blanco is Research Professor at the Severo Ochoa Molecular Biology Centre (CBMSO) of the Spanish National Research Council (CSIC) in Madrid. An expert in DNA polymerases and their applications in biotechnology, he has identified and described several DNA polymerases, including the molecule in the bacteriophage phi29, as well as the human Pol λ, Pol μ and PrimPol enzymes.
He has headed a number of national and international research projects and is the author of over a hundred papers published in major international scientific journals.
Dr Blanco is co-founder of X-Pol Biotech, which merged with SYGNIS in 2012. He is currently one of the main shareholders and a science advisor in this company.
His team have recently found a new human enzyme, PrimPol, a polymerase with primase activity that resumes DNA replication delayed by damage. This has interesting implications for cancer and ageing research. The new enzyme is of direct interest to scientists, as it is bound to spearhead a new generation of polymerases for DNA amplification.
For further information please contact:
Pilar de la Huerta, CEO/CFO